MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-15-2026
Sintx Technologies Retained Earnings 2011-2026 | SINT
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Sintx Technologies
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -292 M | -282 M | -271 M | -262 M | -250 M | -241 M | -234 M | -229 M | -221 M | -213 M | -197 M | -173 M | -140 M | -132 M | -96.6 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -96.6 M | -292 M | -216 M |
Quarterly Retained Earnings Sintx Technologies
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -295 M | -290 M | -286 M | -284 M | -282 M | -280 M | -274 M | -272 M | -271 M | - | -265 M | -263 M | -262 M | -258 M | -256 M | -253 M | -250 M | -248 M | -246 M | -244 M | -241 M | -241 M | -241 M | -241 M | -234 M | -234 M | -234 M | -234 M | -229 M | -229 M | -229 M | -229 M | -221 M | -221 M | -221 M | -221 M | -211 M | -211 M | -211 M | -211 M | -197 M | -197 M | -197 M | -197 M | -173 M | -173 M | -173 M | -173 M | -140 M | -140 M | -140 M | -140 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -140 M | -295 M | -229 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
EDAP TMS S.A.
EDAP
|
-82.6 M | $ 4.3 | -0.69 % | $ 161 M |  France |
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B |  USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-380 M | - | - | $ 3.31 B | USA |
 |
Eargo
EAR
|
-514 M | - | - | $ 10.2 M | USA |
 |
Helius Medical Technologies
HSDT
|
-213 M | $ 2.29 | -2.97 % | $ 50.5 M | USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
-217 M | $ 11.44 | -2.22 % | $ 324 M | USA |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
IRIDEX Corporation
IRIX
|
-92.4 M | $ 1.01 | - | $ 17.1 M | USA |
 |
Alphatec Holdings
ATEC
|
-1.42 B | $ 8.27 | 0.49 % | $ 1.24 B | USA |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
-718 M | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | USA |
 |
LivaNova PLC
LIVN
|
-1.15 B | $ 73.83 | 0.26 % | $ 4.03 B |  Britain |
 |
LENSAR
LNSR
|
-178 M | $ 6.09 | 2.35 % | $ 72.8 M | USA |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-312 M | $ 0.46 | 0.17 % | $ 28.6 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-275 M | $ 18.37 | -0.33 % | $ 431 M | USA |
 |
MiMedx Group
MDXG
|
-42.7 M | $ 3.62 | 0.28 % | $ 535 M | USA |
 |
Delcath Systems
DCTH
|
-529 M | $ 11.02 | -3.76 % | $ 395 M | USA |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Myomo
MYO
|
-119 M | $ 1.04 | 9.47 % | $ 43.5 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Pulmonx Corporation
LUNG
|
-522 M | $ 1.55 | 0.65 % | $ 63.1 M | USA |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Orthofix Medical
OFIX
|
-368 M | $ 10.75 | 3.27 % | $ 426 M |  Curacao |
 |
Neovasc
NVCN
|
-420 M | - | - | $ 111 M |  Canada |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
Profound Medical Corp.
PROF
|
-288 M | $ 6.83 | -2.01 % | $ 206 M | Canada |
 |
Electromed
ELMD
|
21.2 M | $ 38.22 | -0.93 % | $ 323 M | USA |
 |
Butterfly Network
BFLY
|
-879 M | $ 4.47 | -0.22 % | $ 1.1 B | USA |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
-149 M | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
-62.5 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
1.39 B | $ 84.81 | 0.24 % | $ 11.5 B | USA |
 |
Insulet Corporation
PODD
|
287 M | $ 154.87 | -1.29 % | $ 10.9 B | USA |
 |
CONMED Corporation
CNMD
|
589 M | $ 37.23 | 0.57 % | $ 1.16 B | USA |
 |
Inspire Medical Systems
INSP
|
-146 M | $ 43.84 | -2.01 % | $ 1.29 B | USA |
 |
Integer Holdings Corporation
ITGR
|
994 M | $ 89.28 | -0.8 % | $ 3.1 B | USA |
 |
Invacare Corporation
IVC
|
-78.4 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
14.2 B | $ 85.78 | 3.1 % | $ 50.2 B | USA |
 |
TransMedics Group
TMDX
|
-278 M | $ 68.94 | 0.12 % | $ 2.34 B | USA |